Kim C S., Sandberg J A., Slikker W, Binienda Z, Schlosser P M., Patterson T A.
Food and Drug Administration, Division of Toxicological Research (HFS-506), Center for Food Safety and Applied Nutrition, 20204, Washington, DC, USA
Environ Toxicol Pharmacol. 2001 Mar;9(4):153-160. doi: 10.1016/s1382-6689(01)00060-6.
Our objective was to construct a physiologically-based pharmacokinetic (PBPK) model describing the kinetic behavior of 2,4-dichlorophenoxyacetic acid (2,4-D) on rats after long-term exposures to low doses. Our study demonstrated the model's ability to simulate uptake of 2,4-D in discrete areas of the rat brain. The model was derived from the generic PBPK model that was first developed for high-dose, single exposures of 2,4-D to rats or rabbits (Kim, C.S., Gargas, M.L., Andersen, M.E., 1994. Pharmacokinetic modeling of 2,4-dichlorophenoxyacetic acid (2,4-D) in rats and rabbits brain following single dose administration. Toxicol. Lett. 74, 189-201; Kim, C.S., Slikker, W., Jr., Binienda, Z., Gargas, M.L., Andersen, M.E., 1995. Development of a physiologically based pharmacokinetic (PBPK) model for 2,4-dichlorophenoxyacetic acid (2,4-D) dosimetry in discrete areas of the brain following a single intraperitoneal or intravenous dose. Neurotox. Teratol. 17, 111-120.), to which a subcutaneous (hypodermal) compartment was incorporated for low-dose, long-term infusion. It consisted of two body compartments, along with compartments for venous and arterial blood, cerebrospinal fluid, brain plasma and six brain regions. Uptake of the toxin was membrane-limited by the blood-brain barrier with clearance from the brain provided by cerebrospinal fluid 'sink' mechanisms. This model predicted profiles of 2,4-D levels in brain and blood over a 28-day period that compared well with concentrations measured in vivo with rats that had been given 2,4-D (1 or 10 mg/kg per day) with [14C]-2,4-D subcutaneously (s.c.) for 7, 14, or 28 days, respectively. This PBPK model should be an effective tool for evaluating the target tissue doses that may produce the neurotoxicity of organic acid toxicants after low-dose, long-term exposures to contaminated foods or the environment.
我们的目标是构建一个基于生理学的药代动力学(PBPK)模型,以描述长期低剂量暴露后2,4-二氯苯氧乙酸(2,4-D)在大鼠体内的动力学行为。我们的研究证明了该模型模拟2,4-D在大鼠脑离散区域摄取的能力。该模型源自最初为2,4-D高剂量单次暴露于大鼠或兔子而开发的通用PBPK模型(Kim, C.S., Gargas, M.L., Andersen, M.E., 1994. 单次给药后大鼠和兔子脑中2,4-二氯苯氧乙酸(2,4-D)的药代动力学建模。毒理学快报。74, 189 - 给大鼠或兔子(Kim, C.S., Gargas, M.L., Andersen, M.E., 1994. Pharmacokinetic modeling of 2,4-dichlorophenoxyacetic acid (2,4-D) in rats and rabbits brain following single dose administration. Toxicol. Lett. 74, 189 - 201; Kim, C.S., Slikker, W., Jr., Binienda, Z., Gargas, M.L., Andersen, M.E., 1995. Development of a physiologically based pharmacokinetic (PBPK) model for 2,4-dichlorophenoxyacetic acid (2,4-D) dosimetry in discrete areas of the brain following a single intraperitoneal or intravenous dose. Neurotox. Teratol. 17, 111 - 120.),为低剂量长期输注加入了皮下(皮下)隔室。它由两个身体隔室以及静脉血、动脉血、脑脊液、脑血浆和六个脑区域的隔室组成。毒素的摄取受血脑屏障的膜限制,脑脊液的“汇”机制提供从脑的清除。该模型预测了28天内脑和血中2,4-D水平的变化情况,与分别皮下(s.c.)给予[14C]-2,4-D 7、14或28天的大鼠体内测量的浓度相比,吻合度良好。这个PBPK模型应该是评估低剂量长期暴露于受污染食物或环境后可能产生有机酸毒物神经毒性的靶组织剂量的有效工具。